FDA staff: Calcitonin salmon may carry cancer risk

03/3/2013 | Reuters

A link between osteoporosis treatments containing calcitonin salmon and cancer risk is possible, according to briefing documents from FDA staff reviewers. The reviewers raised questions about the drugs' usefulness in preventing bone breaks due to osteoporosis in postmenopausal women, the reviewers said. An FDA panel is set to discuss the products on Tuesday.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA